Newsroom | 38568 results

DUBLIN--(BUSINESS WIRE)--The "Hearing Aids 3D Printing Device Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global hearing aids 3D printing device market is set for significant growth in the coming decade. Estimated at USD 488.7 million in 2024, the market is projected to reach USD 942.2 million by 2033, expanding at a CAGR of 7.59% from 2025 to 2033. This surge is largely driven by the increasing prevalence of hearing loss globally, the growing adoption of p...

WASHINGTON--(BUSINESS WIRE)--Dr. Krishnan Suthanthiran and his TeamBest Global family of companies—recognized innovators in cost-effective technologies for the diagnosis/treatment of cancer and vascular diseases, including theranostics—have issued an open call for deeper collaboration with the Association of Radiation Oncologists of India (AROI). Suthanthiran founded the International Society of Therapeutic Radiology and Oncology (ISTRO) under the Best Cure Foundation (BCF) and the Brachytherap...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Mosaic Clinical Technologies™ (Mosaic), the technology and AI services division of Radiology Partners (RP), today announced the appointment of Mike Peresie as President of Mosaic. Mike joins Mosaic as a seasoned digital health executive with more than two decades of experience leading high-growth innovation portfolios and scaled software, network and data businesses. He brings deep expertise in building technology platforms that improve access, quality and aff...

DUBLIN--(BUSINESS WIRE)--The "Biological Evaluation of Medical Devices Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering. Ensure compliance with the ISO 10993 series of standards for the biological evaluation of medical devices, as it is well-established and expected by regulatory authorities worldwide. In the European Union, compliance with these standards is crucial for meeting the essential safety requirements outlined in the Medical De...

BOSTON--(BUSINESS WIRE)--a2z Radiology AI has received U.S. FDA clearance for a2z-Unified-Triage, a single device that flags and prioritizes seven urgent findings on abdomen-pelvis CT scans simultaneously. With RSNA 2025, radiology's largest annual conference, just days away, a2z is positioning itself as a leader in abdomen-pelvis AI. The company is bringing a first-of-its-kind capability to the U.S. market: a single system that triages seven urgent conditions on abdomen-pelvis CTs in one pass....

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application...

DUBLIN--(BUSINESS WIRE)--The "Breast Imaging Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global breast imaging market is poised for robust growth, projected to expand from USD 5.45 billion in 2024 to USD 9.00 billion by 2030, at a CAGR of 8.9% from 2025 to 2030. This growth is driven by the increasing prevalence of breast cancer, technological advancements in breast imaging, and substantial investments in cancer screening programs. As per the World Cancer R...

TAMPA, Fla.--(BUSINESS WIRE)--The following is an opinion editorial provided by Casey Pittock, CEO, Smart Meter: UnitedHealthcare’s decision to sharply limit remote patient monitoring (RPM) reimbursement beginning January 1, 2026, to heart failure and hypertensive disorders of pregnancy, is a disservice to clinicians, patients, and the healthcare system at large. It contradicts federal momentum to modernize chronic care and misrepresents the weight of current evidence on RPM’s clinical value fo...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the BofA Securities Leveraged Finance Conference, being held in Boca Raton, FL, on Tuesday, December 2, 2025, including a fireside chat at 8:10 a.m. ET. The webcast link will be available on the Com...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today that it has received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstruction technology. Powered by deep learning, Pristina Recon DL sets a new standard in image definition and sharpness. Breast cancer remains one of the most common cancers among women, with one in eight expected to face a diagnosis in their lifetime2 and an estimated 1.1 million breast cancer–related deaths project...